CL-218872

CC1=NN=C2C=CC(=NN12)C3=CC=CC(=C3)C(F)(F)F

InChIKey=GUOQUXNJZHGPQF-UHFFFAOYSA-N

InChI=1S/C13H9F3N4/c1-8-17-18-12-6-5-11(19-20(8)12)9-3-2-4-10(7-9)13(14,15)16/h2-7H,1H3

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Targets

Primary Target	Pharmacology	Condition	Potency
GABA-A receptor; alpha-1/beta-3/gamma-2 16 Target ID: CHEMBL2094121 Sources: https://www.ncbi.nlm.nih.gov/pubmed/10633039 \| https://www.ncbi.nlm.nih.gov/pubmed/14744042	Agonist 2752		57.0 nM [Ki]
GABA-A receptor; alpha-5/beta-3/gamma-2 14 Target ID: CHEMBL2094122 Sources: https://www.ncbi.nlm.nih.gov/pubmed/10633039 \| https://www.ncbi.nlm.nih.gov/pubmed/14744042	Agonist 2752		561.0 nM [Ki]

Substance Class	Chemical Created by `admin` on `Mon Mar 31 17:35:31 GMT 2025` Edited by `admin` on `Mon Mar 31 17:35:31 GMT 2025`
Record UNII	O7GR5XL5B5
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

CI-218872

Preferred Name

English

CL-218872

Code

English

1,2,4-TRIAZOLO(4,3-B)PYRIDAZINE, 3-METHYL-6-(3-(TRIFLUOROMETHYL)PHENYL)-

Systematic Name

English

3-METHYL-6(3-(TRIFLUOROMETHYL)PHENYL)-1,2,4-TRIAZOLO (4.3-B)PYRIDAZINE

Common Name

English

Code System Code Type Description

CAS

66548-69-4